Logo image of EXPE

EXPEDIA GROUP INC (EXPE) Stock Fundamental Analysis

USA - NASDAQ:EXPE - US30212P3038 - Common Stock

218.85 USD
+3.2 (+1.48%)
Last: 10/24/2025, 8:21:46 PM
219 USD
+0.15 (+0.07%)
After Hours: 10/24/2025, 8:21:46 PM
Fundamental Rating

6

Overall EXPE gets a fundamental rating of 6 out of 10. We evaluated EXPE against 133 industry peers in the Hotels, Restaurants & Leisure industry. EXPE has an excellent profitability rating, but there are some minor concerns on its financial health. EXPE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

EXPE had positive earnings in the past year.
EXPE had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EXPE reported negative net income in multiple years.
Of the past 5 years EXPE 4 years had a positive operating cash flow.
EXPE Yearly Net Income VS EBIT VS OCF VS FCFEXPE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

The Return On Assets of EXPE (4.10%) is better than 60.15% of its industry peers.
Looking at the Return On Equity, with a value of 132.42%, EXPE belongs to the top of the industry, outperforming 98.50% of the companies in the same industry.
With an excellent Return On Invested Capital value of 17.00%, EXPE belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
EXPE had an Average Return On Invested Capital over the past 3 years of 10.99%. This is in line with the industry average of 10.67%.
The last Return On Invested Capital (17.00%) for EXPE is above the 3 year average (10.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.1%
ROE 132.42%
ROIC 17%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
EXPE Yearly ROA, ROE, ROICEXPE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

EXPE has a Profit Margin of 7.90%. This is in the better half of the industry: EXPE outperforms 66.17% of its industry peers.
In the last couple of years the Profit Margin of EXPE has grown nicely.
EXPE has a better Operating Margin (12.15%) than 64.66% of its industry peers.
In the last couple of years the Operating Margin of EXPE has grown nicely.
The Gross Margin of EXPE (89.58%) is better than 98.50% of its industry peers.
In the last couple of years the Gross Margin of EXPE has grown nicely.
Industry RankSector Rank
OM 12.15%
PM (TTM) 7.9%
GM 89.58%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
EXPE Yearly Profit, Operating, Gross MarginsEXPE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

EXPE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
EXPE has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EXPE has been reduced compared to 5 years ago.
Compared to 1 year ago, EXPE has an improved debt to assets ratio.
EXPE Yearly Shares OutstandingEXPE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EXPE Yearly Total Debt VS Total AssetsEXPE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 1.17, we must say that EXPE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of EXPE (1.17) is worse than 62.41% of its industry peers.
The Debt to FCF ratio of EXPE is 3.11, which is a good value as it means it would take EXPE, 3.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EXPE (3.11) is better than 80.45% of its industry peers.
EXPE has a Debt/Equity ratio of 5.34. This is a high value indicating a heavy dependency on external financing.
EXPE's Debt to Equity ratio of 5.34 is on the low side compared to the rest of the industry. EXPE is outperformed by 61.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.34
Debt/FCF 3.11
Altman-Z 1.17
ROIC/WACC2.25
WACC7.54%
EXPE Yearly LT Debt VS Equity VS FCFEXPE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

EXPE has a Current Ratio of 0.75. This is a bad value and indicates that EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.75, EXPE is doing worse than 61.65% of the companies in the same industry.
A Quick Ratio of 0.75 indicates that EXPE may have some problems paying its short term obligations.
The Quick ratio of EXPE (0.75) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
EXPE Yearly Current Assets VS Current LiabilitesEXPE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

EXPE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.29%, which is quite impressive.
Measured over the past years, EXPE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.87% on average per year.
The Revenue has been growing slightly by 5.69% in the past year.
The Revenue has been growing slightly by 2.56% on average over the past years.
EPS 1Y (TTM)21.29%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%20.8%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%6.41%

3.2 Future

Based on estimates for the next years, EXPE will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.50% on average per year.
EXPE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.25% yearly.
EPS Next Y16.21%
EPS Next 2Y18.27%
EPS Next 3Y18.05%
EPS Next 5Y15.5%
Revenue Next Year5.5%
Revenue Next 2Y5.96%
Revenue Next 3Y6.45%
Revenue Next 5Y6.25%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXPE Yearly Revenue VS EstimatesEXPE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
EXPE Yearly EPS VS EstimatesEXPE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.63 indicates a correct valuation of EXPE.
74.44% of the companies in the same industry are more expensive than EXPE, based on the Price/Earnings ratio.
EXPE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.89.
EXPE is valuated correctly with a Price/Forward Earnings ratio of 12.78.
EXPE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXPE is cheaper than 78.95% of the companies in the same industry.
EXPE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.99.
Industry RankSector Rank
PE 16.63
Fwd PE 12.78
EXPE Price Earnings VS Forward Price EarningsEXPE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXPE indicates a somewhat cheap valuation: EXPE is cheaper than 66.92% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXPE indicates a rather cheap valuation: EXPE is cheaper than 85.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.56
EV/EBITDA 10.22
EXPE Per share dataEXPE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100

4.3 Compensation for Growth

EXPE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
EXPE has an outstanding profitability rating, which may justify a higher PE ratio.
EXPE's earnings are expected to grow with 18.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.03
PEG (5Y)1.12
EPS Next 2Y18.27%
EPS Next 3Y18.05%

3

5. Dividend

5.1 Amount

EXPE has a yearly dividend return of 0.74%, which is pretty low.
EXPE's Dividend Yield is a higher than the industry average which is at 3.90.
Compared to an average S&P500 Dividend Yield of 2.31, EXPE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.74%

5.2 History

EXPE has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
EXPE Yearly Dividends per shareEXPE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y18.27%
EPS Next 3Y18.05%
EXPE Yearly Income VS Free CF VS DividendEXPE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

EXPEDIA GROUP INC

NASDAQ:EXPE (10/24/2025, 8:21:46 PM)

After market: 219 +0.15 (+0.07%)

218.85

+3.2 (+1.48%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners102.64%
Inst Owner Change-0.15%
Ins Owners0.51%
Ins Owner Change0.25%
Market Cap27.08B
Revenue(TTM)14.02B
Net Income(TTM)1.11B
Analysts72.09
Price Target227.5 (3.95%)
Short Float %5.7%
Short Ratio4.1
Dividend
Industry RankSector Rank
Dividend Yield 0.74%
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date08-28 2025-08-28 (0.4)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.21%
Min EPS beat(2)1.46%
Max EPS beat(2)20.96%
EPS beat(4)3
Avg EPS beat(4)9.14%
Min EPS beat(4)-0.95%
Max EPS beat(4)20.96%
EPS beat(8)7
Avg EPS beat(8)30.51%
EPS beat(12)8
Avg EPS beat(12)-12.48%
EPS beat(16)12
Avg EPS beat(16)3.75%
Revenue beat(2)1
Avg Revenue beat(2)-1.36%
Min Revenue beat(2)-2.83%
Max Revenue beat(2)0.11%
Revenue beat(4)2
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)1.66%
Revenue beat(8)3
Avg Revenue beat(8)-0.81%
Revenue beat(12)3
Avg Revenue beat(12)-1.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.63%
PT rev (1m)0%
PT rev (3m)17.74%
EPS NQ rev (1m)0.36%
EPS NQ rev (3m)2.61%
EPS NY rev (1m)0.47%
EPS NY rev (3m)0.54%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)2.11%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)1.22%
Valuation
Industry RankSector Rank
PE 16.63
Fwd PE 12.78
P/S 1.93
P/FCF 13.56
P/OCF 9.75
P/B 32.39
P/tB N/A
EV/EBITDA 10.22
EPS(TTM)13.16
EY6.01%
EPS(NY)17.12
Fwd EY7.82%
FCF(TTM)16.14
FCFY7.38%
OCF(TTM)22.45
OCFY10.26%
SpS113.3
BVpS6.76
TBVpS-55.12
PEG (NY)1.03
PEG (5Y)1.12
Graham Number44.73
Profitability
Industry RankSector Rank
ROA 4.1%
ROE 132.42%
ROCE 23.13%
ROIC 17%
ROICexc 181.1%
ROICexgc N/A
OM 12.15%
PM (TTM) 7.9%
GM 89.58%
FCFM 14.25%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
ROICexc(3y)20.29%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y125.83%
ROICexc growth 5Y22.57%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
F-Score8
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 5.34
Debt/FCF 3.11
Debt/EBITDA 1.74
Cap/Depr 90.29%
Cap/Sales 5.57%
Interest Coverage 7.92
Cash Conversion 108.18%
Profit Quality 180.4%
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 1.17
F-Score8
WACC7.54%
ROIC/WACC2.25
Cap/Depr(3y)92.88%
Cap/Depr(5y)87.19%
Cap/Sales(3y)5.93%
Cap/Sales(5y)8.19%
Profit Quality(3y)403.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.29%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%20.8%
EPS Next Y16.21%
EPS Next 2Y18.27%
EPS Next 3Y18.05%
EPS Next 5Y15.5%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%6.41%
Revenue Next Year5.5%
Revenue Next 2Y5.96%
Revenue Next 3Y6.45%
Revenue Next 5Y6.25%
EBIT growth 1Y7.31%
EBIT growth 3Y85.19%
EBIT growth 5Y11.61%
EBIT Next Year138.56%
EBIT Next 3Y42.43%
EBIT Next 5Y27.05%
FCF growth 1Y-13.96%
FCF growth 3Y-8.85%
FCF growth 5Y7.7%
OCF growth 1Y-11.08%
OCF growth 3Y-6.28%
OCF growth 5Y2.2%

EXPEDIA GROUP INC / EXPE FAQ

Can you provide the ChartMill fundamental rating for EXPEDIA GROUP INC?

ChartMill assigns a fundamental rating of 5 / 10 to EXPE.


Can you provide the valuation status for EXPEDIA GROUP INC?

ChartMill assigns a valuation rating of 6 / 10 to EXPEDIA GROUP INC (EXPE). This can be considered as Fairly Valued.


What is the profitability of EXPE stock?

EXPEDIA GROUP INC (EXPE) has a profitability rating of 8 / 10.


What is the financial health of EXPEDIA GROUP INC (EXPE) stock?

The financial health rating of EXPEDIA GROUP INC (EXPE) is 3 / 10.